- Capillary blood collection and sampling devices, essential for minimally invasive diagnostic procedures, are becoming increasingly integral in clinical, homecare, and decentralized healthcare settings due to their ease of use, patient comfort, and suitability for point-of-care testing
- The growing demand for these devices is primarily driven by the rising prevalence of chronic conditions such as diabetes, increased adoption of home-based health monitoring, and the expanding use of self-sampling kits for laboratory testing
- U.S. dominated the North American capillary blood collection and sampling devices market, accounting for the largest revenue share in 2024, owing to its advanced diagnostic infrastructure, high frequency of chronic disease screening, and presence of key manufacturers
- Canada is expected to witness the highest compound annual growth rate (CAGR) in the North America capillary blood collection and sampling devices market due to increasing healthcare expenditure, rising awareness around preventive health, and the growing need for decentralized testing.
- Capillary blood collection devices segment dominated the North America capillary blood collection and sampling devices market with a market share of 35.3% in 2024, driven by its widespread use in clinical diagnostics and compatibility with multiple testing platforms
